Silence Therapeutics advanced its RNAi drug for polycythemia vera, shared new Phase 2 trial updates, and reaffirmed a strong ...

MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

Adrenal tumours have become a common incidental finding in the radiological evaluation of patients. Estimates suggest that ...

Te Whatu Ora is standardising oral health data and planning to consolidate dental practice management systems to enable ...

As hospitals and health systems continue to grapple with revenue leakage and clinical denials, many are turning to innovative technologies to bridge the gap between payers and providers. Organizations ...

Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

“Endotyping-informed therapy in the MRI-guided intervention arm led to a reduction in angina burden and an improvement in health-related quality of life,” reported the principal investigator Colin ...

Background Renal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with several high-quality, randomised, placebo-controlled trials demonstrating ...

Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...

There is no doubt artificial intelligence (AI) has the potential to improve access to mental health care. “One could imagine ...